| 000 | 01696 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517080123.0 | ||
| 264 | 0 | _c20170103 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1791-3004 | ||
| 024 | 7 |
_a10.3892/mmr.2016.4850 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXu, Pingping | |
| 245 | 0 | 0 |
_aIsatin inhibits the proliferation and invasion of SH-SY5Y neuroblastoma cells. _h[electronic resource] |
| 260 |
_bMolecular medicine reports _cMar 2016 |
||
| 300 |
_a2757-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aG1 Phase Cell Cycle Checkpoints |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsatin _xpharmacology |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 700 | 1 | _aHou, Lin | |
| 700 | 1 | _aJu, Chuanxia | |
| 700 | 1 | _aZhang, Zheng | |
| 700 | 1 | _aSun, Wenyan | |
| 700 | 1 | _aZhang, Li | |
| 700 | 1 | _aSong, Jinlian | |
| 700 | 1 | _aLv, Yuqiang | |
| 700 | 1 | _aLiu, Lu | |
| 700 | 1 | _aChen, Zhixiang | |
| 700 | 1 | _aWang, Yanhui | |
| 773 | 0 |
_tMolecular medicine reports _gvol. 13 _gno. 3 _gp. 2757-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/mmr.2016.4850 _zAvailable from publisher's website |
| 999 |
_c25703524 _d25703524 |
||